This describes the challenges associated with the pharmacological management of the patient with COPD and multiple comorbid conditions, with a particular focus on the rational use of inhaled corticosteroids. It also provides guidance for the holistic care of such patients in the primary care setting.
It features the impact of comorbidities on treatment choices for patients with COPD, especially with regard to the risks and benefits of inhaled medications including long-acting beta-agonists (LABA) and long-acting muscarinic antagonists (LAMA), with a special focus on inhaled corticosteroids (ICS).
- General action points to improve the management of multimorbid patient with COPD in the primary care setting
- Additional essential action points
- Treatment considerations for the multimorbid patient with COPD
Authors : Ioanna Tsiligianni, Kristian Hoines, Christian Jensen, JanWillem WH Kocks, Bjorn Stallberg, Claudia Vicente, Rudi Peche
Reviewers: Stewart Mercer, Luîs Andres Amorim Alves
Editor: Tracey Lonergan
Funding: Boehringer Ingelheim provided an unrestricted educational grant to support the development, typesetting, printing and associated costs but did not contribute to the content.
Date published: December 2019.
This Desktop Helper will soon be available in Greek, Chinese, French and Spanish. A set of case studies will also follow.